WolverHeme Happy Hour cover art

WolverHeme Happy Hour

WolverHeme Happy Hour

Written by: Bernard Marini Anthony Perissinotti et al.
Listen for free

About this listen

 Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.Bernard Marini, Anthony Perissinotti, et al. Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • ASH Leukemia Review: the more we learn, the less we know!

    ASH Leukemia Review: the more we learn, the less we know!
    Dec 17 2025

    In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change practice? Listen to find out.


    Some of the abstracts discussed:

    • PARADIGM: https://meetings-api.hematology.org/api/abstract/vmpreview/296881
    • KMT2A Outcomes (MARROW Consortium and Othman, et al.): https://meetings-api.hematology.org/api/abstract/vmpreview/302582 and https://meetings-api.hematology.org/api/abstract/vmpreview/297333
    • CLIA +/- Ven: https://meetings-api.hematology.org/api/abstract/vmpreview/302047
    • FLT3i studies (and MRD): https://meetings-api.hematology.org/api/abstract/vmpreview/295719 and https://meetings-api.hematology.org/api/abstract/vmpreview/302699 and https://meetings-api.hematology.org/api/abstract/vmpreview/291322
    • ALL GIMEMA Trial (blin + ponatinib): https://meetings-api.hematology.org/api/abstract/vmpreview/296532
    • Menin inhibitor data
    Show More Show Less
    1 hr and 23 mins
  • RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy

    RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy
    Dec 9 2025

    Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice.

    https://meetings-api.hematology.org/api/abstract/vmpreview/296881

    Show More Show Less
    41 mins
  • MajesTEC-3 and ASH 2025: Let's get "TEC"nical

    MajesTEC-3 and ASH 2025: Let's get "TEC"nical
    Nov 25 2025

    In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3 study!

    Show More Show Less
    1 hr and 10 mins
No reviews yet